Company intelligence / Profile preview

Medulla Pro

Ownership: Private
Development stage: Other

Overview

Medulla Pro is developing intuitive, real-time ultrasound guidance systems to improve the accuracy and safety of needle-based medical procedures such as lumbar punctures and peripheral nerve blocks. The lead product aims to simplify lumbar punctures with ergonomic design and real-time guidance, while a second product enables single-person operation for nerve blocks. Clinical trials are imminent in Singapore. The technology is validated with strong intellectual property and developed in partnership with major healthcare institutions.

Therapeutic areas: Neurology
Modalities: Device
Industry: Medical Imaging

Partnerships

National Healthcare Group Singapore (clinical advisors)Trendlines Innovation Labs/Trendlines Group (incubator/investor)

Beyond the preview

Go deeper on Medulla Pro.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Medulla Pro.

Explore the full profile